{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:28:07Z","timestamp":1769599687379,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"S\u00f8ster og Verner Lipperts fond"},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R302-A17420"],"award-info":[{"award-number":["R302-A17420"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006309","name":"Riisfort Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021817","name":"Knud og Edith Eriksens Mindefond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010347","name":"Fabrikant Einar Willumsens Mindelegat","doi-asserted-by":"publisher","award":["J. nr. 500028"],"award-info":[{"award-number":["J. nr. 500028"]}],"id":[{"id":"10.13039\/501100010347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Andersen-Isted fond"},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","award":["L-2022-00060"],"award-info":[{"award-number":["L-2022-00060"]}],"id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Inge og Asker Larsens Fond","award":["039252-0005 seb\/ruh"],"award-info":[{"award-number":["039252-0005 seb\/ruh"]}]},{"name":"Frimodt-Heinike Fonden"},{"DOI":"10.13039\/501100007438","name":"Familien Hede Nielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007438","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agnethe L\u00f8vgreens Fond"},{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study aimed to establish a feasible large porcine model for dynamic assessment of cisplatin concentrations in carcinomatosis-relevant abdominal tissues using microdialysis during and after HIPEC combined with cytoreductive surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In total, eight pigs underwent open abdominal cytoreductive surgery followed by HIPEC. Microdialysis was employed for dynamic cisplatin concentration sampling in abdominal organs and tissue. Cisplatin dialysate concentrations were analyzed using the UPLC-MS\/MS method. STATA (version 18.0) was used to perform a two-compartment model with a zero-order distribution to analyze pharmacokinetic parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Detectable cisplatin concentrations in the evaluated target tissues persisted for at least 6 h post-HIPEC. Higher concentrations were found in superficial tissues; however, the difference was not statistically significant. The cisplatin concentrations were comparable for the stomach, rectum, and liver but higher in the peritoneal lining of the abdominal wall, with the lowest median average peak concentration (<jats:italic>C<\/jats:italic>\n              <jats:sub>max<\/jats:sub>) in the rectum (0.50 \u00b5g\/mL) and the highest median <jats:italic>C<\/jats:italic>\n              <jats:sub>max<\/jats:sub> in the peritoneum (2.80 \u00b5g\/mL). No statistically significant differences in cisplatin area under the curve from time zero to the time of the last sample collection (AUC<jats:sub>0\u2013last<\/jats:sub>) were found between any of the abdominal compartments except the peritoneal lining of the abdominal wall, which was significantly higher compared with most of the other abdominal tissues {smallest difference; peritoneum 1\/liver 2; 1.96 [95% confidence interval (CI) 0.90; 4.26, <jats:italic>P<\/jats:italic> = 0.09] and largest difference; peritoneum 3\/rectum profound; 4.60 [95% CI 1.94; 10.90, <jats:italic>P<\/jats:italic> = 0.001]}.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our investigation revealed comparable cisplatin concentrations across abdominal organ surfaces, except higher concentrations in the peritoneal lining of the abdominal wall than in the stomach, rectum, and liver. This model holds promise for future research into HIPEC interventions and anticancer effectiveness.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-17000-w","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T18:03:51Z","timestamp":1739383431000},"page":"3804-3813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dynamic Assessment of Local Abdominal Tissue Concentrations of Cisplatin During a HIPEC Procedure: Insights from a Porcine Model"],"prefix":"10.1245","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7255-9557","authenticated-orcid":false,"given":"Christina","family":"Harlev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Bue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth Krogsgaard","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Ren\u00e9","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Martin","family":"Bibby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelle","family":"Hanberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Vibeke","family":"Schmedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone Kjeld","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiken","family":"Stilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"issue":"1","key":"17000_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3978\/j.issn.2078-6891.2015.111","volume":"7","author":"MD Goodman","year":"2016","unstructured":"Goodman MD, McPartland S, Detelich D, Saif MW. Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy. J Gastrointest Oncol. 2016;7(1):45\u201357. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.111.","journal-title":"J Gastrointest Oncol."},{"issue":"3","key":"17000_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1708618.","journal-title":"N Engl J Med."},{"issue":"2","key":"17000_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","volume":"243","author":"MJ Koppe","year":"2006","unstructured":"Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243(2):212\u201322. https:\/\/doi.org\/10.1097\/01.sla.0000197702.46394.16.","journal-title":"Ann Surg."},{"issue":"41","key":"17000_CR4","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","volume":"19","author":"F Coccolini","year":"2013","unstructured":"Coccolini F, Gheza F, Lotti M, et al. Peritoneal carcinomatosis. World J Gastroenterol. 2013;19(41):6979\u201394. https:\/\/doi.org\/10.3748\/wjg.v19.i41.6979.","journal-title":"World J Gastroenterol."},{"issue":"8","key":"17000_CR5","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3748\/wjg.14.1159","volume":"14","author":"HA Al-Shammaa","year":"2008","unstructured":"Al-Shammaa HA, Li Y, Yonemura Y. Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol. 2008;14(8):1159\u201366. https:\/\/doi.org\/10.3748\/wjg.14.1159.","journal-title":"World J Gastroenterol."},{"issue":"10","key":"17000_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S1470-2045(23)00396-0","volume":"24","author":"SL Aronson","year":"2023","unstructured":"Aronson SL, Lopez-Yurda M, Koole SN, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial. Lancet Oncol. 2023;24(10):1109\u201318. https:\/\/doi.org\/10.1016\/S1470-2045(23)00396-0.","journal-title":"Lancet Oncol."},{"key":"17000_CR7","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-13932-3","author":"A Bhatt","year":"2023","unstructured":"Bhatt A, Glehen O, Zivanovic O, et al. The 2022 PSOGI international consensus on hipec regimens for peritoneal malignancies: epithelial ovarian cancer. Ann Surg Oncol. 2023. https:\/\/doi.org\/10.1245\/s10434-023-13932-3.","journal-title":"Ann Surg Oncol."},{"key":"17000_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.06.022","author":"S Kusamura","year":"2019","unstructured":"Kusamura S, Azmi N, Fumagalli L, et al. Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791). Eur J Surg Oncol. 2019. https:\/\/doi.org\/10.1016\/j.ejso.2019.06.022."},{"issue":"3","key":"17000_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00228-012-1405-4","volume":"69","author":"PH Cashin","year":"2013","unstructured":"Cashin PH, Ehrsson H, Wallin I, Nygren P, Mahteme H. Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis. Eur J Clin Pharmacol. 2013;69(3):533\u201340. https:\/\/doi.org\/10.1007\/s00228-012-1405-4.","journal-title":"Eur J Clin Pharmacol."},{"issue":"2b","key":"17000_CR10","first-page":"1643","volume":"23","author":"S Zeamari","year":"2003","unstructured":"Zeamari S, Floot B, van der Vange N, Stewart FA. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC). Anticancer Res. 2003;23(2b):1643\u20138.","journal-title":"Anticancer Res"},{"issue":"6","key":"17000_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/SLA.0b013e3182582b38","volume":"256","author":"O Facy","year":"2012","unstructured":"Facy O, Al Samman S, Magnin G, et al. High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study. Ann Surg. 2012;256(6):1084\u20138. https:\/\/doi.org\/10.1097\/SLA.0b013e3182582b38.","journal-title":"Ann Surg."},{"issue":"1","key":"17000_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/02656736.2019.1704891","volume":"37","author":"A Davigo","year":"2020","unstructured":"Davigo A, Passot G, Vassal O, et al. PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model. Int J Hyperthermia. 2020;37(1):144\u201350. https:\/\/doi.org\/10.1080\/02656736.2019.1704891.","journal-title":"Int J Hyperthermia."},{"issue":"3","key":"17000_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1515\/pp-2022-0110","volume":"7","author":"EK Petersen","year":"2022","unstructured":"Petersen EK, Bue M, Harlev C, et al. Abdominal tissue concentrations and penetration of carboplatin in a HIPEC procedure\u2014assessment in a novel porcine model. Pleura Peritoneum. 2022;7(3):117\u201325. https:\/\/doi.org\/10.1515\/pp-2022-0110.","journal-title":"Pleura Peritoneum."},{"issue":"2\u20133","key":"17000_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/s0169-409x(00)00107-1","volume":"45","author":"EC de Lange","year":"2000","unstructured":"de Lange EC, de Boer AG, Breimer DD. Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv Drug Deliv Rev. 2000;45(2\u20133):125\u201348. https:\/\/doi.org\/10.1016\/s0169-409x(00)00107-1.","journal-title":"Adv Drug Deliv Rev."},{"issue":"5","key":"17000_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00280-009-1085-7","volume":"65","author":"S Jacobs","year":"2010","unstructured":"Jacobs S, McCully CL, Murphy RF, Bacher J, Balis FM, Fox E. Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates. Cancer Chemother Pharmacol. 2010;65(5):817\u201324. https:\/\/doi.org\/10.1007\/s00280-009-1085-7.","journal-title":"Cancer Chemother Pharmacol."},{"issue":"3","key":"17000_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1359-4117.2002.01019.x","volume":"2","author":"MJ Johansen","year":"2002","unstructured":"Johansen MJ, Thapar N, Newman RA, Madden T. Use of microdialysis to study platinum anticancer agent pharmacokinetics in preclinical models. J Exp Ther Oncol. 2002;2(3):163\u201373. https:\/\/doi.org\/10.1046\/j.1359-4117.2002.01019.x.","journal-title":"J Exp Ther Oncol"},{"issue":"2","key":"17000_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1128\/cmr.00092-12","volume":"26","author":"D Gonzalez","year":"2013","unstructured":"Gonzalez D, Schmidt S, Derendorf H. Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents. Clin Microbiol Rev. 2013;26(2):274\u201388. https:\/\/doi.org\/10.1128\/cmr.00092-12.","journal-title":"Clin Microbiol Rev."},{"issue":"5","key":"17000_CR18","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1007\/s12035-016-9929-8","volume":"54","author":"CM Kho","year":"2017","unstructured":"Kho CM, Enche Ab Rahim SK, Ahmad ZA, Abdullah NS. A review on microdialysis calibration methods: the theory and current related efforts. Mol Neurobiol. 2017;54(5):3506\u201327. https:\/\/doi.org\/10.1007\/s12035-016-9929-8.","journal-title":"Mol Neurobiol."},{"key":"17000_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010078","author":"R Helderman","year":"2019","unstructured":"Helderman R, L\u00f6ke DR, Kok HP, et al. Variation in clinical application of hyperthermic intraperitoneal chemotherapy: a review. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11010078.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"17000_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ijc.29011","volume":"136","author":"O Zivanovic","year":"2015","unstructured":"Zivanovic O, Abramian A, Kullmann M, et al. HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer. Int J Cancer. 2015;136(3):699\u2013708. https:\/\/doi.org\/10.1002\/ijc.29011.","journal-title":"Int J Cancer."},{"issue":"5","key":"17000_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2527\/jas1973.365927x","volume":"36","author":"KW Kelley","year":"1973","unstructured":"Kelley KW, Curtis SE, Marzan GT, Karara HM, Anderson CR. Body surface area of female swine. J Anim Sci. 1973;36(5):927\u2013930. https:\/\/doi.org\/10.2527\/jas1973.365927x","journal-title":"J Anim Sci."},{"key":"17000_CR22","doi-asserted-by":"publisher","first-page":"1240440","DOI":"10.1016\/j.jchromb.2024.124040","volume":"1235","author":"AV Schmedes","year":"2024","unstructured":"Schmedes AV, Harlev C, Bue M, et al. Analysis of free cisplatin in microdialysates and plasma ultrafiltrate by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2024;1235:1240440. https:\/\/doi.org\/10.1016\/j.jchromb.2024.124040.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci."},{"key":"17000_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25204733","author":"G Kireeva","year":"2020","unstructured":"Kireeva G, Kruglov S, Maydin M, et al. Modeling of chemoperfusion vs. intravenous administration of cisplatin in Wistar rats: adsorption and tissue distribution. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25204733.","journal-title":"Molecules."},{"issue":"2","key":"17000_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0300985811402846","volume":"49","author":"MM Swindle","year":"2012","unstructured":"Swindle MM, Makin A, Herron AJ, Clubb FJ Jr, Frazier KS. Swine as models in biomedical research and toxicology testing. Vet Pathol. 2012;49(2):344\u201356. https:\/\/doi.org\/10.1177\/0300985811402846.","journal-title":"Vet Pathol."},{"issue":"3","key":"17000_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1568009023333836","volume":"2","author":"Y Luo","year":"2002","unstructured":"Luo Y, Prestwich GD. Cancer-targeted polymeric drugs. Curr Cancer Drug Targets. 2002;2(3):209\u201326. https:\/\/doi.org\/10.2174\/1568009023333836.","journal-title":"Curr Cancer Drug Targets."},{"key":"17000_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111229","volume":"116","author":"T Haider","year":"2020","unstructured":"Haider T, Sandha KK, Soni V, Gupta PN. Recent advances in tumor microenvironment associated therapeutic strategies and evaluation models. Mater Sci Eng C Mater Biol Appl. 2020;116:111229. https:\/\/doi.org\/10.1016\/j.msec.2020.111229.","journal-title":"Mater Sci Eng C Mater Biol Appl."},{"issue":"6","key":"17000_CR27","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412. https:\/\/doi.org\/10.1371\/journal.pbio.1000412.","journal-title":"PLoS Biol."},{"issue":"8","key":"17000_CR28","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/jor.24588","volume":"38","author":"MB Thomassen","year":"2020","unstructured":"Thomassen MB, Hanberg P, Stilling M, et al. Local concentrations of gentamicin obtained by microdialysis after a controlled application of a GentaColl sponge in a porcine model. J Orthop Res. 2020;38(8):1793\u20139. https:\/\/doi.org\/10.1002\/jor.24588.","journal-title":"J Orthop Res."},{"issue":"4","key":"17000_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5194\/jbji-6-99-2021","volume":"6","author":"J Olsen Kipp","year":"2021","unstructured":"Olsen Kipp J, Hanberg P, Slater J, et al. Vancomycin bone and tissue concentrations following tibial intraosseous administration\u2014evaluated in a porcine model. J Bone Joint Infect. 2021;6(4):99\u2013106. https:\/\/doi.org\/10.5194\/jbji-6-99-2021.","journal-title":"J Bone Joint Infect."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17000-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17000-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17000-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:22:22Z","timestamp":1744096942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17000-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["17000"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17000-w","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.ejso.2019.06.022","asserted-by":"subject"}]},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by the Danish Cancer Society (R302-A17420); S\u00f8ster og Verner Lipperts Fund; Inge og Asker Larsens Fund (039252-0005 seb\/ruh); A.P. M\u00f8ller Foundation (L-2022-00060), Andersen-Isted Fund; Fabrikant Einar Willumsens Mindelegat (J. no. 500028); Agnethe L\u00f8vgreens Fund; Familien Hede Nielsens Fund; Frimodt-Heinike Foundation; Knud og Edith Eriksens Minde Fund; and Riisfort Foundation. The authors report no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}